Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. [electronic resource]
Producer: 20010712Description: 898-902 p. digitalISSN:- 0887-6924
- Adolescent
- Adult
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Asparaginase -- administration & dosage
- Bone Marrow Transplantation
- Carmustine -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Gram-Negative Bacterial Infections -- etiology
- Humans
- Immunocompromised Host
- Infusions, Intravenous
- Injections, Intravenous
- Life Tables
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neutropenia -- chemically induced
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- administration & dosage
- Remission Induction
- Survival Analysis
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.